Jyoti Gupta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jyoti Gupta has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Anjana Goel
GLA University, Mathura, India
1 shared publication - Baldomero Oliva
Department of Medicine and Life Sciences, (Structural Bioinformatics Group-GRIB), Universitat Pompeu Fabra , Barcelona, Catalonia 08003
1 shared publication Istuti Saraswat
GLA University, Department of Biotechnology, 17km stone, NH-19, Mathura-Delhi Road, Mathura, 281406, India
1 shared publication- Istuti Saraswat
Department of Biotechnology, GLA University, Mathura, India
1 shared publication - Rajeev K. Tyagi
Division of Cell Biology and Immunology, Biomedical Parasitology and Translational-Immunology Lab, CSIR-Institute of Microbial Technology (IMTECH), Sec−39A, Chandigarh 160036, Chandigarh, India
1 shared publication - Reetesh Kumar
Department of Biotechnology and Bioengineering, School of Biosciences & Technology, Galgotias University, Greater Noida 201310, Gautam Buddha Nagar, India
1 shared publication
Latest Publications
- 21 September 2026
- Published by Springer Nature in BioNanoScience
- Vol. 16 (10) , 643
Deciphering the Anti-oxidant and Anti-Inflammatory Activities of Green-Synthesized Silver Nanoparticles from Argemone mexicana Linn
- 21 September 2026
- Published by Springer Nature in BioNanoScience
- Vol. 16 (10) , 643
Deciphering the Anti-oxidant and Anti-Inflammatory Activities of Green-Synthesized Silver Nanoparticles from Argemone mexicana Linn
- 25 May 2026
- Published by Bentham Science Publishers Ltd. in Current Protein & Peptide Science
- Vol. 27
Modulation of the Unfolded Protein Response by Viruses: Mechanistic Insights and Implications for viral Pathogenesis
The endoplasmic reticulum (ER) is essential for protein synthesis, folding, maturation, transport, and calcium storage in mammalian cells. Perturbations in ER homeostasis, caused by stressors such as hypoxia, oxidative stress, or infection result in the accumulation of unfolded or misfolded proteins, triggering ER stress. To restore equilibrium, cells activate the unfolded protein response (UPR), a conserved adaptive mechanism mediated by three major ER transmembrane anchored stress sensors: IRE1, PERK, and ATF6. These sensors coordinate translational attenuation, chaperone upregulation, protein degradation, and lipid synthesis to mitigate ER stress and sustain cell survival. However, chronic or dysregulation UPR can induce apoptosis, inflammation, or autophagy. Viruses exploit ER stress and UPR pathway to promote their replication, immune evasion, and persistent infection, highlighting the dual role of the UPR in both host defense and viral survival. A comprehensive understanding of viral modulation of the UPR may reveal novel therapeutic opportunities, offering potential antiviral strategies by targeting host stress response pathways. This review explores how viruses use the UPR to control cell stress and metabolic pathways, and thereby enhance replication and progeny formation, or undergo cell death.
- 25 May 2026
- Published by Bentham Science Publishers Ltd. in Current Protein & Peptide Science
- Vol. 27
Modulation of the Unfolded Protein Response by Viruses: Mechanistic Insights and Implications for viral Pathogenesis
The endoplasmic reticulum (ER) is essential for protein synthesis, folding, maturation, transport, and calcium storage in mammalian cells. Perturbations in ER homeostasis, caused by stressors such as hypoxia, oxidative stress, or infection result in the accumulation of unfolded or misfolded proteins, triggering ER stress. To restore equilibrium, cells activate the unfolded protein response (UPR), a conserved adaptive mechanism mediated by three major ER transmembrane anchored stress sensors: IRE1, PERK, and ATF6. These sensors coordinate translational attenuation, chaperone upregulation, protein degradation, and lipid synthesis to mitigate ER stress and sustain cell survival. However, chronic or dysregulation UPR can induce apoptosis, inflammation, or autophagy. Viruses exploit ER stress and UPR pathway to promote their replication, immune evasion, and persistent infection, highlighting the dual role of the UPR in both host defense and viral survival. A comprehensive understanding of viral modulation of the UPR may reveal novel therapeutic opportunities, offering potential antiviral strategies by targeting host stress response pathways. This review explores how viruses use the UPR to control cell stress and metabolic pathways, and thereby enhance replication and progeny formation, or undergo cell death.
- Open Access
- 28 August 2025
- Published by MDPI AG in BioMedInformatics
- Vol. 5 (3) , 47
Stabilizing the Shield: C-Terminal Tail Mutation of HMPV F Protein for Enhanced Vaccine Design
Background: Human Metapneumovirus (HMPV) is a respiratory virus in the Pneumoviridae family. HMPV is an enveloped, negative-sense RNA virus encoding three surface proteins: SH, G, and F. The highly immunogenic fusion (F) protein is essential for viral entry and a key target for vaccine development. The F protein exists in two conformations: prefusion and postfusion. The prefusion form is highly immunogenic and considered a potent vaccine antigen. However, this conformation needs to be stabilized to improve its immunogenicity for effective vaccine development. Specific mutations are necessary to maintain the prefusion state and prevent it from changing to the postfusion form. Methods: In silico mutagenesis was performed on the C-terminal domain of the pre-F protein, focusing on five amino acids at positions 469 to 473 (LVDQS), using the established pre-F structure (PDB: 8W3Q) as the reference. The amino acid sequence was sequentially mutated based on hydrophobicity, resulting in mutants M1 (IIFLL), M2 (LLIVL), M3 (WWVLL), and M4 (YMWLL). Increasing hydrophobicity was found to enhance protein stability and structural rigidity. Results: Epitope mapping revealed that all mutants displayed significant B and T cell epitopes similar to the reference protein. The structure and stability of all mutants were analyzed using molecular dynamics simulations, free energy calculations, and secondary structure analysis. Based on the lowest RMSD, clash score, MolProbity value, stable radius of gyration, and low RMSF, the M1 mutant demonstrated superior structural stability. Conclusions: Our findings indicate that the M1 mutant of the pre-F protein could be the most stable and structurally accurate candidate for vaccine development against HMPV.
- 28 August 2025
- Published by MDPI AG in BioMedInformatics
- Vol. 5 (3) , 47
Open AccessStabilizing the Shield: C-Terminal Tail Mutation of HMPV F Protein for Enhanced Vaccine Design
Background: Human Metapneumovirus (HMPV) is a respiratory virus in the Pneumoviridae family. HMPV is an enveloped, negative-sense RNA virus encoding three surface proteins: SH, G, and F. The highly immunogenic fusion (F) protein is essential for viral entry and a key target for vaccine development. The F protein exists in two conformations: prefusion and postfusion. The prefusion form is highly immunogenic and considered a potent vaccine antigen. However, this conformation needs to be stabilized to improve its immunogenicity for effective vaccine development. Specific mutations are necessary to maintain the prefusion state and prevent it from changing to the postfusion form. Methods: In silico mutagenesis was performed on the C-terminal domain of the pre-F protein, focusing on five amino acids at positions 469 to 473 (LVDQS), using the established pre-F structure (PDB: 8W3Q) as the reference. The amino acid sequence was sequentially mutated based on hydrophobicity, resulting in mutants M1 (IIFLL), M2 (LLIVL), M3 (WWVLL), and M4 (YMWLL). Increasing hydrophobicity was found to enhance protein stability and structural rigidity. Results: Epitope mapping revealed that all mutants displayed significant B and T cell epitopes similar to the reference protein. The structure and stability of all mutants were analyzed using molecular dynamics simulations, free energy calculations, and secondary structure analysis. Based on the lowest RMSD, clash score, MolProbity value, stable radius of gyration, and low RMSF, the M1 mutant demonstrated superior structural stability. Conclusions: Our findings indicate that the M1 mutant of the pre-F protein could be the most stable and structurally accurate candidate for vaccine development against HMPV.
- Open Access
- 19 January 2017
- Published by Springer Nature in Parasites & Vectors
- Vol. 10 (1) , 34
RNA interference mediated knockdown of Brugia malayi UDP-Galactopyranose mutase severely affects parasite viability, embryogenesis and in vivo development of infective larvae
Galactofuranose is an essential cell surface component present in bacteria, fungi and several nematodes such as Caenorhabditis spp., Brugia spp., Onchocerca spp. and Strongyloides spp. This sugar maintains the integrity of parasite surface and is essential for virulence. UDP-Galactopyranose mutase (bmugm) plays a key role in Galf biosynthesis by catalyzing conversion of UDP-Galactopyranose into UDP-galactofuranose and knockout studies of the gene in Leishmania major, Mycobacterium and Aspergillus fumigatus displayed attenuated virulence while RNA interference study in C. elegans exhibited detrimental effects. Presence of UGM in several prokaryotic and eukaryotic microbial pathogens and its absence in higher eukaryotes renders it an attractive drug target. In the present study, RNA interference studies have been carried out to validate bmugm as an antifilarial drug target. RNA interference studies using two different sequences of siRNAs targeting bmugm were carried out. The in vitro gene silencing of adult B. malayi parasites was undertaken to observe the effects on parasites. Infective larvae were also exposed to siRNAs and their in vivo development in jirds was observed. The in vitro gene silencing induced by siRNA1 and 2 individually as well as together knocked down the bmugm gene expression causing impaired viability of the exposed worms along with extremely reduced motility, abridged microfilarial release and adversely effected embryogenesis. The combinatorial in vitro gene silencing revealed marginally better results than both the siRNAs individually. Thus, infective larvae were treated with siRNA combination which showed downregulation of bmugm mRNA expression resulting into sluggish larval movements and/or death. The siRNA-treated actively motile larvae when inoculated intraperitoneally into jirds demonstrated highly reduced transformation of these larvae into adult worms with detrimental effects on embryogenesis. The effects of gene silencing were long-lasting as the adult worms developed from siRNA-treated larvae showed noticeable knockdown in the target gene expression. The validation studies undertaken here conclude that bmugm is essential for the proper development and survival of the parasite and support its candidature as an antifilarial drug target.
- 19 January 2017
- Published by Springer Nature in Parasites & Vectors
- Vol. 10 (1) , 34
Open AccessRNA interference mediated knockdown of Brugia malayi UDP-Galactopyranose mutase severely affects parasite viability, embryogenesis and in vivo development of infective larvae
Galactofuranose is an essential cell surface component present in bacteria, fungi and several nematodes such as Caenorhabditis spp., Brugia spp., Onchocerca spp. and Strongyloides spp. This sugar maintains the integrity of parasite surface and is essential for virulence. UDP-Galactopyranose mutase (bmugm) plays a key role in Galf biosynthesis by catalyzing conversion of UDP-Galactopyranose into UDP-galactofuranose and knockout studies of the gene in Leishmania major, Mycobacterium and Aspergillus fumigatus displayed attenuated virulence while RNA interference study in C. elegans exhibited detrimental effects. Presence of UGM in several prokaryotic and eukaryotic microbial pathogens and its absence in higher eukaryotes renders it an attractive drug target. In the present study, RNA interference studies have been carried out to validate bmugm as an antifilarial drug target. RNA interference studies using two different sequences of siRNAs targeting bmugm were carried out. The in vitro gene silencing of adult B. malayi parasites was undertaken to observe the effects on parasites. Infective larvae were also exposed to siRNAs and their in vivo development in jirds was observed. The in vitro gene silencing induced by siRNA1 and 2 individually as well as together knocked down the bmugm gene expression causing impaired viability of the exposed worms along with extremely reduced motility, abridged microfilarial release and adversely effected embryogenesis. The combinatorial in vitro gene silencing revealed marginally better results than both the siRNAs individually. Thus, infective larvae were treated with siRNA combination which showed downregulation of bmugm mRNA expression resulting into sluggish larval movements and/or death. The siRNA-treated actively motile larvae when inoculated intraperitoneally into jirds demonstrated highly reduced transformation of these larvae into adult worms with detrimental effects on embryogenesis. The effects of gene silencing were long-lasting as the adult worms developed from siRNA-treated larvae showed noticeable knockdown in the target gene expression. The validation studies undertaken here conclude that bmugm is essential for the proper development and survival of the parasite and support its candidature as an antifilarial drug target.